Maker of the Oura smart ring for monitoring sleep, activity and heart health.
Around 1,480 people on the team.
Oura, the Finnish maker of the Oura smart ring for sleep, activity and heart-health monitoring, has raised $1275M across four rounds from a backer base that mixes health and growth capital, including Dexcom, ICONIQ, The Chernin Group, Fidelity, Atreides Management and Whale Rock. Through shared capital it connects most closely to Anthropic and Cerebras Systems (three common investors each), with weaker ties to Skyryse and Woebot Health (two each). With a connection score of 50, Oura sits at the intersection of consumer health and the AI/frontier-compute cluster anchored by Anthropic and Cerebras Systems rather than inside a single tight investor group. Its team of 1480 is concentrated in the San Francisco Bay Area (30%) and New York (10%).
| Date | Round | Amount |
|---|---|---|
| Oct 2025 | Funding round Oura raised over $900 million led by Fidelity at a valuation of around $11 billion. | $900M |
| Dec 2024 | Series D Plus Oura raised a $200M Series D at a $5.2B valuation to expand its AI-driven health features and global reach, with Fidelity and Dexcom participating. | $200M |
| Nov 2024 | Growth Oura received a $75M strategic investment from glucose monitor maker Dexcom, pushing its valuation above $5B ahead of a 2025 device and app integration. | $75M |
| May 2021 | Series C Oura, the Finnish maker of the Oura smart ring, raised a $100M Series C led by The Chernin Group and Elysian Park, at around an $800M valuation. | $100M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.